Bids Are Invited For Acquisition Of Medicines For Hurhc.

Pharmacological Group: Antibacterials, Active Ingredient: Ceftazidime, Pharmaceutical Form: Injectable Lyophilic Powder, Concentration / Dosage: 1, Unit: G, Volume: Not Applicable, Presentation: Not Applicable, Accessory: Not Applicable, Active Ingredient: Clarithromycin, Concentration / Dosage: 500, Unit: Mg, Presentation: Vial-Ampule, Pharmacological Group: Hydroelectrolytic Solutions And Acid-Base Balance Correctors, Active Ingredient: Glycerin Enema, Pharmaceutical Form: Liquid, Concentration / Dosage: 12, Unit: %, Volume: 500 Ml, Presentation: Bottle/Pouch, Accessory: With Kit, Delivery Form: Unit, Treatment: Alginate, Color: Colorless, Application: Necrotized Wounds, Supply: 85 G, Pharmacological Group: Peripheral Neuromuscular Blockers And Anticholinesterasics, Active Ingredient: Suxamethonium Chloride (Succinylcholine), Pharmaceutical Form: Lyophilized Powder, Concentration / Dosage: 100, Volume: N/A, Accessory: N/A, Pharmacological Group: Antibiotic, Active Ingredient: Tigecycline, Concentration/Dosage: 50, Pharmacological Group: Antiseptics, Active Ingredient: Ethyl Alcohol, Pharmaceutical Form: Topical Solution, Concentration/Dosage: 70, Volume: 100 Ml, Presentation: Bottle, Pharmacological Group: Germicides, Active Ingredient: Chlorhexidine Gluconate, Form Pharmaceutical: Degerming Solution - Almotolia, Concentration / Dosage: 2%, Volume: 100Ml, Pharmacological Group: Antifungals, Active Ingredient: Anidulafungin